EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma

Ritu Chaudhary(Moffitt Cancer Center), Christine H. Chung(Moffitt Cancer Center)

Cancer Research Communications

May 4, 2023

10.1158/2767-9764.crc-22-0443

Cited by 13

Related Papers

Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

|The Lancet Oncology|2019|537

Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas

|Science Translational Medicine|2015|502

Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma

|PLoS ONE|2010|165

Surgical salvage improves overall survival for patients with HPV‐positive and HPV‐negative recurrent locoregional and distant metastatic oropharyngeal cancer

|Cancer|2015|148

Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus–Related Oropharyngeal Carcinoma

|JAMA Oncology|2015|98